A monoclonal antibody (NMC‐VIII/10) to factor VIII light chain recognizing Glu1675–Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells
- 1 August 1992
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 81 (4), 533-538
- https://doi.org/10.1111/j.1365-2141.1992.tb02988.x
Abstract
The monoclonal antibody NMC-VIII/10 is a neutralizing antibody which recognizes the Glu1675-Glu1684 sequence of the factor VIII light chain and inhibits factor VIII (FVIII) binding to immobilized von Willebrand factor (vWf). In this study we immunohistochemically determined, using human umbilical cord tissue, whether or not NMC-VIII/10 has an inhibitory effect on FVIII binding to endogenous vWF in endothelial cells. Tissue sections were reacted with purified FVIII followed by peroxidase-conjugated monoclonal antibody (C5) recognizing the 54 kD fragment of the FVIII heavy chain. The labelling pattern of bound FVIII was similar to that of endogenous vWF and appeared as a fine granular deposit in the endothelial cells. Addition of purified vWF completely inhibited the binding of FVIII to endothelial cells. Furthermore, FVIII did not bind to endothelium in the presence of 0.25 M CaCl2, and similarly, thrombin-treated FVIII did not bind to the vascular site. These findings suggested that FVIII was bound to endogenous vWF in the endothelial cells. The binding reaction was completely inhibited by NMC-VIII/10, confirming that the monoclonal antibody recognizes the specific epitope responsible for FVIII binding to endogenous vWF.Keywords
This publication has 22 references indexed in Scilit:
- Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.JCI Insight, 1989
- Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.JCI Insight, 1988
- Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.JCI Insight, 1988
- Distribution of factor VIII mRNA and antigen in human liver and other tissuesNature, 1985
- Biosynthesis of von Willebrand protein by human megakaryocytes.JCI Insight, 1985
- Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's diseaseBritish Journal of Haematology, 1982
- Synthesis of Factor VIII Antigen by Cultured Guinea Pig MegakaryocytesJCI Insight, 1977
- Stabilization of Factor VIII in Plasma by the von Willebrand FactorJCI Insight, 1977
- Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial CellsJCI Insight, 1973
- Antihemophilic Factor Antigen. LOCALIZATION IN ENDOTHELIAL CELLS BY IMMUNOFLUORESCENT MICROSCOPYJCI Insight, 1973